Article Details

Ventus will Aim $140 Million at Previously Undruggable Targets | BioSpace

Retrieved on: 2022-02-10 12:51:20

Tags for this article:

Click the tags to see associated articles and topics

Ventus will Aim $140 Million at Previously Undruggable Targets | BioSpace. View article details on HISWAI: https://www.biospace.com/article/ventus-therapeutics-snags-140-million-to-drive-lead-assets-into-the-clinic

Excerpt

... $140 million in a Series C financing round less than two years after launching to develop therapies aimed at diseases of the innate immune system.

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up